Journals / Türk Oftalmoloji Dergisi / 2012 / Cilt: 42 - Sayı: 1

Comparison of total oxidative stress, total antioxidant capacity, and paraoxonase, arylesterase, and lipid peroxidase levels in aqueous humor and serum of diabetic and non-diabetic patients with cataract

Diyabetik ve diyabetik olmayan katarakt hastalarında hümör aközde ve serumda total oksidatif stres, total antioksidan kapasite, paraoksonaz, arilesteraz ve lipidperoksidaz seviyelerinin karşılaştırılması

Pages
47–52
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When groups 1 and 2 were compared with control group, it was found that in group 1, PON 1 was statistically significantly low and HbA1c was high, while in group 2, TOS and HbA1c were high and TAC and PON 1 were low (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pur po se: The aim was to compare total oxidative stress (TOS), total antioxidant capacity (TAC), and paraoxonase (PON1), arylesterase (ARE), and lipid peroxidase (LPO) levels in the aqueous humor and concurrent venous blood serum and to evaluate the role of oxidative stress in the progression of diabetic retinopathy in diabetic and non-diabetic patients with cataract.
📊
Key Findings & Data:Ma te ri al and Met hod: Oxidative tissue and organ damage play a significant role in diabetes and related complications.
💡
Conclusion & Impact:When groups 1 and 2 were compared with control group, it was found that in group 1, PON 1 was statistically significantly low and HbA1c was high, while in group 2, TOS and HbA1c were high and TAC and PON 1 were low (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pur po se: The aim was to compare total oxidative stress (TOS), total antioxidant capacity (TAC), and paraoxonase (PON1), arylesterase (ARE), and lipid peroxidase (LPO) levels in the aqueous humor and concurrent venous blood serum and to evaluate the role of oxidative stress in the progression of diabetic retinopathy in diabetic and non-diabetic patients with cataract. Ma te ri al and Met hod: Oxidative tissue and organ damage play a significant role in diabetes and related complications. A reduction in the activities of antioxidant enzymes such as superoxide dismutase, glutathione peroxidase, glutathione reductase and catalase has been reported in both blood and lens samples. PON1, ARE, and LPO are unreviewed antioxidant enzymes until now. We included diabetic and non-diabetic patients who were admitted to our clinic for complaints of hazy vision and who received the diagnosis of cataract. Patients were divided into 3 groups: group 1 - diabetic patients without retinopathy, group 2- with diabetic retinopathy, and group 3 - patients without systemic disease outside the diagnosis of cataract. A total of 78 patients (26 patients in each group) were enrolled in the study. Re sults: In this study, there was no statistically significant difference among the groups for TOS, TAC, PON1, ARE and LPO levels in aqueous humor. Although simultaneous venous blood serum results, TOS, TAC, PON1 and HbA1c levels in all 3 groups were found statistically significant, ARE and LPO were not statistically significant. When groups 1 and 2 were compared with control group, it was found that in group 1, PON 1 was statistically significantly low and HbA1c was high, while in group 2, TOS and HbA1c were high and TAC and PON 1 were low (p

Özet

Amaç: Diyabetik ve diyabetik olmayan katarakt hastalarında hümör aközde ve eş zamanlı venöz kan serumunda, total oksidatif stres (TOS), total antioksidan kapasite (TAK), paraoksonaz (PON1), arilesteraz (ARE), lipid peroksidaz (LPO) seviyelerini karşılaştırmak ve diyabetik retinopatinin ilerlemesinde oksidatif stresin rolünü değerlendirmek. Ge­reç ve Yön­tem: Oksidatif doku ve organ hasarı, diyabette ve komplikasyonlarında rol oynar. Hem kanda hem de lens örneklerinde süperoksit dismutaz, glutatyon peroksidaz, glutatyon redüktaz ve katalaz gibi antioksidan enzim aktivitelerindeki azalmalar bildirilmiştir. PON1, ARE, LPO şimdiye kadar incelenmeyen antioksidan enzimlerdir. Kliniğimize puslu görme şikayeti ile başvuran ve katarakt tanısı alıp, cerrahi tedavi önerilen diyabetik ve diyabetik olmayan hastalar dahil edildi. Diyabeti olup retinopatisi olmayan hastalar 1. grup, diyabetik retinopatili hastalar 2. grup ve katarakt tanısı dışında ek sistemik hastalığı olmayan hastalar 3. grup olarak ayrıldı. Her bir grup 26 hasta olacak şekilde toplam 78 hasta çalışmaya dahil edildi.Sonuçlar: Bu çalışmada hümör aköz TOS, TAK, PON1 ve ARE ve LPO düzeyleri açısından gruplar arasında istatistiksel olarak anlamlı bir fark bulunmadı. Her 3 grubun eş zamanlı venöz kan serumu sonuçları, TOS, TAK, PON1 ve HbA1c düzeyleri istatistiksel olarak önemli bulunmuşken, ARE ve LPO açısından önemsiz bulundu. Grup 1 ve 2, kontrol grubu ile karşılaştırıldığında, Grup 1’de istatistiksel olarak anlamlı oranda PON 1 düşük, HbA1c yüksek, Grup 2’de TOS ve HbA1c yüksek, TAK ve PON 1 düşük bulundu (P

🔖

Cite This Article

TOKER, M. İ., AYDIN, H., VURAL, A. Ö., ERDOĞAN, H., TOPALKARA, A., CANER, C., ARICI, M. K. (2022). Comparison of total oxidative stress, total antioxidant capacity, and paraoxonase, arylesterase, and lipid peroxidase levels in aqueous humor and serum of diabetic and non-diabetic patients with cataract. Türk Oftalmoloji Dergisi, Cilt: 42 - Sayı: 1, 47–52. https://ajindex.com/articles/638279

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J. 1993;291:529-35
  2. Flynn HW Jr, İn: Smiddy WE, ed. Diabetes and Ocular Diseases: Past, Present, and Future Therapies. Ophthalmology Monograph 14. San Francisco; American Academy of Ophthalmology; 2000;226:49-53
  3. Hartnett ME, Stratton RD, Browne RW, et al. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care. 2000;23:234-40
  4. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetes patients. Free Radical & Medicine. 1998;25:369-72
  5. Behnding A, Svensson B, Marklund S, Karisson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci. 1998;39:471-5
  6. Özdin M, Gürsu MF. Koroner kalp hastaları ile çesitli risk faktörlerini tasıyan bireylerde paraoksonaz 1 ve arilesteraz aktiviteleri ile fenotiplerinin arastırılması. Uzmanlık Tezi, Elazığ:Fırat Üniversitesi Tıp Fakültesi, Biyokimya ve Klinik Biyokimya Anabilim Dalı, 2003
  7. Li WF, Costa LG, Furlong CE. Serum paraoxonase status: A major factor in determining resistance to organophosphates. J Toxicol Environ Health. 1993;40:337-46
  8. Gürsu M.F, Özdin M. Sigara içenlerde serum paraoksonaz (PON1) aktiviteleri ile malondialdehit düzeylerinin arastırılması. Fırat Tıp Dergisi. 2002;7:732-7 9. Memişoğulları R, Akçay F. Hiperhomosisteinemide Biyokimyasal Mekanizmalar. Türk Klinik Biyokimya Dergisi 2004;2(1):41-9
  9. Altan N., Dinçel A., Koca C. Diyabetes Mellitus ve Oksidatif stres Türk Biyokimya Dergisi. 2006;31:51-6
  10. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant Status and Lipid Peroxidation in Type II Diabetes Mellitus. Cell Biochem Func. 2003;21:291-6
  11. Memişoğulları R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. Journal of Diabetes and Its Complications. 2004;18(4):193-7
  12. Alper G. Diyabet. In: Onat T, Emerk K, Sözmen EY, (eds). İnsan Biyokimyası. Ankara, Palme Yayıncılık, 2002:248-57
  13. Ostenson C. G. The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiologica Scandinavica 2001;171:241-7
  14. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. Journal of Diabetes and Its Complications 2001;15:203-10
  15. Memişoğulları R. Plazma Homosistein Düzeyleri ile